Medical Condition News

RSS

Research: Higher BMI liked with increased risk of hearing loss in women

According to the World Health Organization, 360 million people have disabling hearing loss, a condition that is often considered to be an unavoidable side effect of aging.

26 Nov 2013

FDA grants priority review status to Avedro's riboflavin ophthalmic solution/KXL system

Avedro Inc, a Boston-based ophthalmic medical device and pharmaceutical company announces that it received notification from the U.S. Food and Drug Administration stating that their NDA for riboflavin ophthalmic solution/KXL system has been filed, and has been granted priority review status. The priority review status places the application action date at March 15th, 2014.

25 Nov 2013

PCBs banned by the US 3 decades ago hurt seniors' cognitive performance

Although PCBs have been banned in the United States since 1979, University of Montreal and CHU Sainte-Justine researcher Maryse Bouchard has found that higher levels of the toxin was associated with lower cognitive performance in seniors.

25 Nov 2013

Researchers identify potential therapeutic target in treatment of certain AML

Acute myeloid leukemia (AML) is a group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities. Mutations of CEBPA, a tumour suppressor, are found in about 10 per cent of human AML patients. In two separate studies on CEBPA mutations in AML subtypes, researchers successfully identified and validated a gene known as Sox4 as a potential therapeutic target and a class of anti-cancer drugs, histone deacetylase (HDAC) inhibitors, as potential candidates in the treatment of certain AML.

25 Nov 2013

DSMB reviews safety data from Phase I/IIa clinical trial of NTCELL for Parkinson’s disease

Living Cell Technologies Limited today announced that the independent data safety monitoring board has reviewed the safety data from the initial patient in the Phase I/IIa clinical trial of NTCELL and advised that implants for the additional three patients in the trial can proceed.

25 Nov 2013

Waseda University researchers observe molecular motors that play critical role in chromosome transport

Researchers at Waseda University in Japan have for the first time directly observed the “molecular motor”, called Xkid, that plays a critical role in facilitating the proper alignment of chromosomes during cell division. Their findings are expected to contribute greatly to elucidating the molecular mechanisms of chromosome segregation, a key aspect of the development of certain medical disorders including cancer and birth defects.

25 Nov 2013

UV radiation: A central factor behind Queensland’s record rates of Merkel cell carcinoma

Queensland has at least double the rates of the world’s deadliest skin cancer on record – yet much of the state are unaware the rare cancer even exists.

25 Nov 2013

Nutranomics joins Genesar Nutraceuticals to acquire worldwide licence for GenEpic

Nutranomics, Inc. is pleased to announce that the Company has completed a Licence Agreement with Genesar Nutraceuticals, LLC to acquire the worldwide exclusive marketing and distributing rights to GenEpic, a natural therapeutic treatment formula currently the subject of an IRB reviewed phase II human clinical study on prostate cancer treatment and recovery.

25 Nov 2013

High intake of sugar-sweetened beverages reports increased risk of endometrial cancer

Postmenopausal women who consumed sugar-sweetened beverages were more likely to develop the most common type of endometrial cancer compared with women who did not drink sugar-sweetened beverages, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

25 Nov 2013

Phase 1/2 clinical trial data for VAL-083 in glioblastoma is presented at 18th Annual SNO meeting

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of interim data from a Phase 1/2 clinical trial for VAL-083 in recurrent glioblastoma (GBM) at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18th Annual Society for Neuro-Oncology (SNO) meeting in San Francisco.

25 Nov 2013

BMI or measure of obesity does not play significant role in weight loss operation, says study

A new study investigating why obese patients choose one type of weight loss operation over another reveals that the main factors influencing decision making are whether patients have type 2 diabetes, how much weight they want to lose, and their tolerance for surgical risk to achieve their ideal weight.

25 Nov 2013

SCCA honored as Non-Profit of the Year for providing much-needed service to community

Seattle Cancer Care Alliance and its specialty gift and oncology services store, Shine, were recently recognized by the South Lake Union Chamber of Commerce for their contributions to the community. SCCA was honored as Non-Profit of the Year for offering outstanding benefits and contributions to the community and for providing a much-needed service with a measureable outcome of results. Shine was recognized as Retailer of the Year for being a local South Lake Union retail store that demonstrated excellence in service, products, substantial growth, and community involvement.

25 Nov 2013

New study led by CDC reports nearly half of US children are diagnosed with ADHD

A new study published in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) found that an estimated two million more children in the United States (U.S.) have been diagnosed with attention-deficit/hyperactivity disorder (ADHD) between 2003-04 and 2011-12.

25 Nov 2013

Tuna sashimi consumption can increase rates of cardiovascular disease

The study showed that tuna sashimi contains the highest levels of methylmercury in fish-sushi, based on samples taken from across the USA.

25 Nov 2013

Patients with symptom clusters after surgery for esophageal cancer have increased mortality risk

A new study has found that several months after surgery for esophageal cancer, different symptoms cluster together in different types of patients. In addition, patients with certain symptom clusters have an increased risk of dying from their disease.

25 Nov 2013

UCL scientists show widespread differences in how genes get expressed in men and women's brains

UCL scientists have shown that there are widespread differences in how genes, the basic building blocks of the human body, are expressed in men and women's brains.

25 Nov 2013

Researchers discover how type 2 diabetes drug metformin actually works

Researchers from St. Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with researchers at McMaster University in Canada, are reportedly the first to discover how the type 2 diabetes drug metformin actually works, providing a molecular understanding that could lead to the development of more effective therapies. Mass spectrometry technologies from AB SCIEX, a global leader in analytical technologies, played a critical role in the analysis that led to this breakthrough finding.

25 Nov 2013

Japanese health authorities approve Aerocrine's NIOX MINO for assessing airway inflammation

Aerocrine AB announces today that Japanese health authorities have approved the use of its FeNO-measuring device NIOX MINO as a tool for assessing patients with airway inflammation such as asthma.

25 Nov 2013

Transarterial embolization procedure helps reduce body weight

A new study reports that individuals who underwent embolization of the left gastric artery for gastrointestinal bleeding experienced a 7.9 percent decrease in body weight three months after the procedure. Results of the study, which offer a potential new avenue for obesity research, will be presented next week at the annual meeting of the Radiological Society of North America.

25 Nov 2013

Researchers identify two gene mutations associated with increased risk of eating disorders

Eating disorders are disturbing and often-heartbreaking ailments that are relatively common, mostly among younger women.

25 Nov 2013

Medical Condition News

Research: Higher BMI liked with increased risk of hearing loss in women

FDA grants priority review status to Avedro's riboflavin ophthalmic solution/KXL system

PCBs banned by the US 3 decades ago hurt seniors' cognitive performance

Researchers identify potential therapeutic target in treatment of certain AML

DSMB reviews safety data from Phase I/IIa clinical trial of NTCELL for Parkinson’s disease

Waseda University researchers observe molecular motors that play critical role in chromosome transport

UV radiation: A central factor behind Queensland’s record rates of Merkel cell carcinoma

Nutranomics joins Genesar Nutraceuticals to acquire worldwide licence for GenEpic

High intake of sugar-sweetened beverages reports increased risk of endometrial cancer

Phase 1/2 clinical trial data for VAL-083 in glioblastoma is presented at 18th Annual SNO meeting

BMI or measure of obesity does not play significant role in weight loss operation, says study

SCCA honored as Non-Profit of the Year for providing much-needed service to community

New study led by CDC reports nearly half of US children are diagnosed with ADHD

Tuna sashimi consumption can increase rates of cardiovascular disease

Patients with symptom clusters after surgery for esophageal cancer have increased mortality risk

UCL scientists show widespread differences in how genes get expressed in men and women's brains

Researchers discover how type 2 diabetes drug metformin actually works

Japanese health authorities approve Aerocrine's NIOX MINO for assessing airway inflammation

Transarterial embolization procedure helps reduce body weight

Researchers identify two gene mutations associated with increased risk of eating disorders

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News